drugset / Trial / NCT02250274

Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents

NCT02250274 ↗

RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to assess the serologic and cell-mediated immune response to licensed live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in children 5-17 years old. The effects of prior infection and or prior season vaccination will be examined. Children will be followed during the influenza season to identify laboratory-confirmed influenza (i.e. vaccine failure).

Timeline

Start
2014-09
Primary completion
2014-12
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject IIV Vaccine — —
Subject LAIV Vaccine — —

Indications